The Empowerment Model Towards Type 2 Diabetic Adults To Enhance Vegetable Intake in Achieving Glycemic Control

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01828242

Acronym

EDMID

Enrollment

Registered

2013-04-10

Start date

2013-01-31

Completion date

2014-12-31

Last updated

2015-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Control for Diabetes Mellitus

Keywords

HbA1C

Brief summary

Life style changes, particularly in dietary patterns have contributed a great deal to the incidence and risks of type 2 Diabetes. Decreased intakes of vegetables and fruits replaced by pre processed food, added sugar and those of animal origin lead towards rapid increase of adult-onset-diabetes. In spite of the knowledge of the benefit of consuming vegetable and fruits, and people are well informed, they still need to be committed to perform a behavior and implement these intention. Behavioral approach methods have demonstrated successful adherence in health education with life style changes. Objective: To identify the impact of The Empowerment Model to enhance vegetable intake in Type 2 Diabetes Mellitus adults in achieving glycemic control.

Interventions

BEHAVIORALEmpowerment model to improve dietary intake

Empowerment model using specific guidelines to improve dietary intake

OTHERControl group following conventional approach

Control group following conventional approach

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Inclusion criteria

* fasting blood glucose ≥126 mg/dL * HbA1C \>8%

Exclusion criteria

* those who have serious, unstable medical conditions, or related to metabolic disorders (i.e. thyroid diseases) * significant co-morbid illnesses such as liver disease, kidney disease, cancer, bowel diseases/ malfunction, pregnancy or nursing mothers.

Design outcomes

Primary

Measure	Time frame
HbA1C	Baseline (week 0), Endline (week 12)

Secondary

Measure	Time frame
Post Prandial blood glucose	Daily for 12 weeks
Fasting Blood Glucose	Daily for 12 weeks

Other

Measure	Time frame
Iron status	Baseline (week 0), Endline (week 12)

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026